AVITA Medical, Inc. (ASX:AVH)

AVITA Medical Statistics

Total Valuation

AVITA Medical has a market cap or net worth of AUD 175.06 million. The enterprise value is 205.34 million.

Market Cap	175.06M
Enterprise Value	205.34M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+4.20%
Shares Change (QoQ)	+7.68%
Owned by Insiders (%)	1.13%
Owned by Institutions (%)	17.33%
Float	30.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.60
PB Ratio	-17.37
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.80
EV / Sales	2.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.66

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.21
Interest Coverage	-0.20

Financial Efficiency

Return on equity (ROE) is -1,746.27% and return on invested capital (ROIC) is -54.82%.

Return on Equity (ROE)	-1,746.27%
Return on Assets (ROA)	-36.33%
Return on Invested Capital (ROIC)	-54.82%
Return on Capital Employed (ROCE)	-2,218.40%
Weighted Average Cost of Capital (WACC)	115.52%
Revenue Per Employee	421,012
Profits Per Employee	-282,347
Employee Count	260
Asset Turnover	1.00
Inventory Turnover	1.75

Taxes

In the past 12 months, AVITA Medical has paid 71,059 in taxes.

Income Tax	71,059
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.64% in the last 52 weeks. The beta is 1.80, so AVITA Medical's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	-61.64%
50-Day Moving Average	1.11
200-Day Moving Average	1.52
Relative Strength Index (RSI)	45.96
Average Volume (20 Days)	492,923

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	16.68

Income Statement

In the last 12 months, AVITA Medical had revenue of AUD 109.46 million and -73.41 million in losses. Loss per share was -2.74.

Revenue	109.46M
Gross Profit	91.67M
Operating Income	-63.63M
Pretax Income	-73.34M
Net Income	-73.41M
EBITDA	-60.52M
EBIT	-63.63M
Loss Per Share	-2.74

Balance Sheet

The company has 35.25 million in cash and 67.69 million in debt, with a net cash position of -32.45 million.

Cash & Cash Equivalents	35.25M
Total Debt	67.69M
Net Cash	-32.45M
Net Cash Per Share	n/a
Equity (Book Value)	-10.08M
Book Value Per Share	-0.33
Working Capital	-30.94M

Cash Flow

In the last 12 months, operating cash flow was -51.16 million and capital expenditures -4.98 million, giving a free cash flow of -56.14 million.

Operating Cash Flow	-51.16M
Capital Expenditures	-4.98M
Free Cash Flow	-56.14M
FCF Per Share	n/a

Margins

Gross margin is 83.74%, with operating and profit margins of -58.12% and -67.06%.

Gross Margin	83.74%
Operating Margin	-58.12%
Pretax Margin	-67.00%
Profit Margin	-67.06%
EBITDA Margin	-55.29%
EBIT Margin	-58.12%
FCF Margin	n/a

Dividends & Yields

AVITA Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.20%
Shareholder Yield	-4.20%
Earnings Yield	-41.93%
FCF Yield	-32.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 24, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Jun 24, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

AVITA Medical has an Altman Z-Score of -8.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.24
Piotroski F-Score	2